Status:
UNKNOWN
Effect of Re-esterified Triglyceride (rTG) Form Omega-3 Supplements on Dry Eye Following Cataract Surgery
Lead Sponsor:
Samsung Medical Center
Conditions:
Dry Eye
Eligibility:
All Genders
Phase:
NA
Brief Summary
To evaluate the clinical outcomes of the systemic re-esterified triglyceride (rTG) form of omega-3 fatty acids in patients with dry eye symptoms after cataract surgery
Eligibility Criteria
Inclusion
- Non complicated cataract surgery
- Patients with dry eye symptom
Exclusion
- Using steroid eyedops,
- Using antibiotics eyedrops
- Surgery other than Cataract surgery
- Contact lens wearer
- Other systemic disease
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04411615
Start Date
July 1 2020
End Date
February 28 2021
Last Update
June 2 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.